| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 5VB.F returned +251.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +141.1% |
| 1 year | +251.2% |
| 5 years | -101.2% |
| All-time high | €8.62 (May 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 5VB.F would be worth today ›No. Nykode Therapeutics AS has not paid a dividend in the past 12 months.
Nykode Therapeutics AS is part of the Healthcare sector.
Nykode Therapeutics AS has a market cap of 124.09M EUR, based on the latest quote.
Nykode Therapeutics AS is scheduled to report earnings on Aug 26, 2026.
